Richard C. Young & Co., Ltd. Merck & Co., Inc. Transaction History

Richard C. Young & Co., Ltd.

$775 Million
Q2 2024

A detailed history of Richard C. Young & Co., Ltd. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Richard C. Young & Co., Ltd. holds 195,412 shares of MRK stock, worth $21.5 Million. This represents 3.12% of its overall portfolio holdings.

Number of Shares

195,412

Previous 193,750 0.86%

Holding current value

$21.5 Million

Previous $25.6 Million 5.37%

% of portfolio

3.12%

Previous 3.41%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$123.8 - $132.96 $205,755 - $220,979	1,662 Added 0.86%	195,412 $24.2 Million
Q1 2024 May 08, 2024	SELL	$113.24 - $131.95 $246,749 - $287,519	-2,179 Reduced 1.11%	193,750 $25.6 Million
Q4 2023 Feb 12, 2024	BUY	$100.18 - $109.02 $186,234 - $202,668	1,859 Added 0.96%	195,929 $21.4 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $32,223 - $35,785	-313 Reduced 0.16%	194,070 $20 Million
Q2 2023 Aug 08, 2023	BUY	$108.61 - $118.38 $101,658 - $110,803	936 Added 0.48%	194,383 $22.4 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $317,261 - $353,998	-3,082 Reduced 1.57%	193,447 $20.6 Million
Q4 2022 Feb 10, 2023	SELL	$87.44 - $112.11 $144,713 - $185,542	-1,655 Reduced 0.84%	196,529 $21.8 Million
Q3 2022 Nov 10, 2022	SELL	$84.53 - $94.96 $1,437 - $1,614	-17 Reduced 0.01%	198,184 $17.1 Million
Q2 2022 Aug 03, 2022	BUY	$83.49 - $94.64 $230,766 - $261,584	2,764 Added 1.41%	198,201 $18.1 Million
Q1 2022 May 06, 2022	BUY	$73.51 - $82.4 $34,917 - $39,140	475 Added 0.24%	195,437 $16 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $269,026 - $336,989	3,722 Added 1.95%	194,962 $14.4 Million
Q3 2021 Nov 10, 2021	BUY	$71.68 - $78.83 $151,603 - $166,725	2,115 Added 1.12%	191,240 $14.4 Million
Q2 2021 Aug 11, 2021	BUY	$70.31 - $77.77 $315,270 - $348,720	4,484 Added 2.43%	189,125 $14.7 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $588,615 - $693,328	8,548 Added 4.85%	184,641 $14.2 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $433,993 - $481,643	6,047 Added 3.56%	176,093 $14.4 Million
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $3.73 Million - $4.22 Million	50,912 Added 42.74%	170,046 $14.1 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $111,122 - $126,445	-1,578 Reduced 1.31%	119,134 $9.21 Million
Q1 2020 May 11, 2020	BUY	$63.36 - $87.82 $181,336 - $251,340	2,862 Added 2.43%	120,712 $9.29 Million
Q4 2019 Feb 12, 2020	BUY	$77.58 - $87.54 $290,381 - $327,662	3,743 Added 3.28%	117,850 $10.7 Million
Q3 2019 Oct 29, 2019	BUY	$76.08 - $82.93 $149,877 - $163,372	1,970 Added 1.76%	114,107 $9.61 Million
Q2 2019 Aug 06, 2019	BUY	$69.84 - $81.59 $186,682 - $218,090	2,673 Added 2.44%	112,137 $9.4 Million
Q1 2019 May 09, 2019	BUY	$69.58 - $79.36 $7.62 Million - $8.69 Million	109,464 New	109,464 $9.1 Million

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $279B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Richard C. Young & Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Richard C. Young & Co., Ltd. with notifications on news.

Account

Richard C. Young & Co., Ltd. Merck & Co., Inc. Transaction History